dapsone has been researched along with Leprosy, Borderline in 62 studies
Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
Excerpt | Relevance | Reference |
---|---|---|
"A study was undertaken with the aim of testing the usefulness of clofazimine as a prophylactic agent against neuritis and nerve damage." | 9.08 | Does clofazimine have a prophylactic role against neuritis? ( Arunthathi, S; Satheesh, KK, 1997) |
"Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported." | 7.72 | A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient. ( Bhat, RM; Radhakrishnan, K, 2003) |
"In Paraguay, the National Leprosy/Tuberculosis Program is based on a combined chemotherapy with isoprodian and rifampicin." | 7.67 | Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients. ( Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S, 1989) |
"A study was undertaken with the aim of testing the usefulness of clofazimine as a prophylactic agent against neuritis and nerve damage." | 5.08 | Does clofazimine have a prophylactic role against neuritis? ( Arunthathi, S; Satheesh, KK, 1997) |
"Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported." | 3.72 | A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient. ( Bhat, RM; Radhakrishnan, K, 2003) |
"The feasibility and effects of a 3-year treatment using rifampicin (RFP), clofazimine (B663) and dapsone (DDS) in multibacillary leprosy patients in Yangzhou Prefecture and Dongtai County (1983-1986) are reported." | 3.68 | Effect of three-year multidrug therapy in multibacillary leprosy patients. ( Ji, F; Li, W; Luo, J; Tao, M; Wang, C; Yang, Z; Ye, G, 1990) |
"In Paraguay, the National Leprosy/Tuberculosis Program is based on a combined chemotherapy with isoprodian and rifampicin." | 3.67 | Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients. ( Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S, 1989) |
"No confirmed relapse has been observed within a follow-up period of 6 months to 7 years and 3 months [59 person-years at risk (PYR)] for TT/BT patients and of 4 months to 5 years and 10 months (100 PYR) for BB/BL/LL patients." | 2.68 | Daily multidrug therapy for leprosy; results of a fourteen-year experience. ( Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D, 1997) |
"Current treatment of leprosy involves use of 3 drugs: rifampicin (rifampin); clofazimine; and dapsone." | 2.41 | Leprosy. Recognition and treatment. ( Ramos-e-Silva, M; Rebello, PF, 2001) |
"Treatment with prednisolone (60 mg/d) along with WHO MDT-MB continued." | 1.39 | Optic nerve involvement in a borderline lepromatous leprosy patient on multidrug therapy. ( Abhinav, C; Chander, B; Chauhan, PS; Khatri, G; Mahajan, VK; Mehta, KS; Prabha, N; Sharma, SK; Sharma, V; Tuli, R, 2013) |
"We report a case of borderline tuberculoid leprosy in a 31-year-old woman." | 1.37 | Facial tuberculoid leprosy: case report. ( Ali, K; Malik, MA; Sittampalam, G, 2011) |
"Dapsone treated group showed a disability rate of 63." | 1.28 | Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh). ( Arora, SK; Girdhar, M; Mohan, L; Mukhija, RD, 1989) |
" It is suggested that dapsone dosage be regulated to body weight and preferably not to exceed 1." | 1.28 | Investigations into the haemolytic effects of dapsone therapy in leprosy patients. ( Balakrishnan, S; Karthikeyan, S; Ramu, G, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (17.74) | 18.7374 |
1990's | 26 (41.94) | 18.2507 |
2000's | 13 (20.97) | 29.6817 |
2010's | 11 (17.74) | 24.3611 |
2020's | 1 (1.61) | 2.80 |
Authors | Studies |
---|---|
Chew, R | 1 |
Woods, ML | 1 |
Fischer, M | 1 |
de Nardo Vanzela, T | 1 |
Bernardes Filho, F | 1 |
Wambier, CG | 1 |
Faria, FM | 1 |
Foss, NT | 1 |
Frade, MAC | 1 |
Yang, S | 1 |
Makredes, M | 1 |
O'Donnell, P | 1 |
Levin, NA | 1 |
El Morabite, K | 1 |
Tbatou, F | 1 |
Ait Ourhroui, M | 1 |
Senouci, K | 1 |
Hassam, B | 1 |
Prabha, N | 1 |
Mahajan, VK | 1 |
Sharma, SK | 1 |
Sharma, V | 1 |
Chauhan, PS | 1 |
Mehta, KS | 1 |
Abhinav, C | 1 |
Khatri, G | 1 |
Chander, B | 1 |
Tuli, R | 1 |
Fu, X | 1 |
Liu, H | 1 |
Zhang, F | 1 |
Gopinath, H | 1 |
Nayak, K | 1 |
Kumar, P | 1 |
Chakraborti, S | 1 |
Asz-Sigall, D | 1 |
López-García, L | 1 |
Neme-Yunes, Y | 1 |
Yuen-Palos, R | 1 |
Vega-Memije, ME | 1 |
Arenas, R | 1 |
Chakma, JK | 1 |
Girdhar, A | 2 |
Natrajan, M | 2 |
Kumar, A | 1 |
Girdhar, BK | 2 |
Manifold, R | 1 |
Marshman, G | 1 |
Ali, K | 1 |
Sittampalam, G | 1 |
Malik, MA | 1 |
Manga, NM | 1 |
Poda, A | 1 |
Bazolo, N | 1 |
Sané, O | 1 |
Batista, G | 1 |
Guèye, NF | 1 |
Sow, PS | 1 |
Badiane, CI | 1 |
Marzano, AV | 1 |
Tosi, D | 1 |
Cusini, M | 1 |
Nunzi, E | 1 |
Massone, C | 1 |
Crosti, C | 1 |
Aftab, H | 1 |
Nielsen, SD | 1 |
Nielsen, SL | 1 |
Due, E | 1 |
Bygbjerg, IC | 1 |
Thybo, S | 1 |
Bhat, RM | 1 |
Radhakrishnan, K | 1 |
Armour, KS | 1 |
Scolyer, RA | 1 |
Barnetson, RS | 1 |
Miladi, MI | 1 |
Feki, I | 1 |
Bahloul, Z | 1 |
Jlidi, R | 1 |
Mhiri, C | 1 |
Al-Raqum, HA | 1 |
Uppal, SS | 1 |
El Abdalghani, RA | 1 |
Lasheen, I | 1 |
Arora, SK | 2 |
Meyer, M | 1 |
Ingen-Housz-Oro, S | 1 |
Ighilahriz, O | 1 |
Wendling, J | 1 |
Gaulier, A | 1 |
Levy-Weil, F | 1 |
Sigal-Grinberg, M | 1 |
Flageul, B | 2 |
Ramos, A | 1 |
Roustán, G | 1 |
Angel-Moreno, A | 1 |
Suárez, E | 1 |
Jayakumar, J | 1 |
Aschhoff, M | 1 |
Job, CK | 2 |
Katoch, K | 3 |
Yadav, VS | 1 |
Bhatia, AS | 1 |
Kar, PK | 1 |
Arora, PN | 1 |
Ramasastry, CV | 1 |
Dhaka, RS | 1 |
Hiran, S | 1 |
Pande, TK | 1 |
Rizvi, SA | 1 |
Vishwanathan, KA | 1 |
Jamet, P | 1 |
Blanc, L | 1 |
Fayne, OC | 1 |
Traore, I | 1 |
Bobin, P | 1 |
Mendis, S | 1 |
Somasiri, KG | 1 |
Chularatna, W | 1 |
Tyagi, PY | 1 |
Oommen, T | 1 |
Roche, PW | 2 |
Britton, WJ | 2 |
Failbus, SS | 2 |
Neupane, KD | 2 |
Theuvenet, WJ | 2 |
Chauhan, SL | 1 |
Malaviya, GN | 1 |
Husain, S | 1 |
Mukherjee, A | 1 |
Fegan, D | 1 |
Glennon, J | 1 |
Thompson, K | 2 |
Sampaio, EP | 1 |
Malta, AM | 1 |
Sarno, EN | 1 |
Kaplan, G | 1 |
de Carsalade, GY | 1 |
Wallach, D | 1 |
Spindler, E | 1 |
Pennec, J | 1 |
Cottenot, F | 1 |
Pavithran, K | 1 |
Satish, TC | 1 |
Arunthathi, S | 1 |
Satheesh, KK | 1 |
Sehgal, VN | 2 |
Kumar, S | 1 |
Jain, S | 1 |
Bhattacharya, SN | 2 |
Young, RJ | 1 |
Gilson, RT | 1 |
Elston, DM | 1 |
Ramos-e-Silva, M | 1 |
Rebello, PF | 1 |
Siccoli, M | 1 |
Bassetti, C | 1 |
Becx-Bleumink, M | 2 |
Cho, SN | 1 |
Mathai, R | 1 |
George, S | 1 |
Jacob, M | 1 |
Constant-Desportes, M | 1 |
Guelpa-Lauras, CC | 1 |
Carolina, JC | 1 |
Léoture, A | 1 |
Grosset, JH | 1 |
Sansarricq, H | 1 |
Natarajan, M | 1 |
Bagga, A | 1 |
Katoch, VM | 2 |
Thomas, A | 1 |
Balakrishnan, A | 1 |
Nagarajan, M | 1 |
Prabhakar, R | 1 |
Tripathy, SP | 1 |
Christian, M | 1 |
Somasundaram, PR | 1 |
Sharma, VK | 2 |
Mathur, RP | 1 |
Li, W | 1 |
Ye, G | 1 |
Yang, Z | 1 |
Tao, M | 1 |
Luo, J | 1 |
Wang, C | 1 |
Ji, F | 1 |
Girdhar, M | 1 |
Mohan, L | 1 |
Mukhija, RD | 1 |
Kulkarni, V | 1 |
Gharpuray, MB | 1 |
Kulkarni, DS | 1 |
Ramu, G | 2 |
Ramanathan, U | 1 |
Sengupta, U | 1 |
Sharma, VD | 1 |
Shivannavar, CT | 1 |
Gallo, ME | 1 |
Damasco, MH | 1 |
Alburquerque, EC | 1 |
Silva, TC | 1 |
Almeida, SM | 1 |
Pritze, S | 1 |
Alvarenga, AE | 1 |
Leguizamon, O | 1 |
Haubitz, I | 1 |
Chatterjee, G | 1 |
Kaur, S | 1 |
Vaishnavi, C | 1 |
Ganguly, NK | 1 |
Balakrishnan, S | 1 |
Karthikeyan, S | 1 |
Li, HY | 1 |
Yu, XL | 1 |
Zhang, MS | 1 |
Duan, CX | 1 |
Huang, WB | 1 |
Zhang, SB | 1 |
Zhu, K | 1 |
Ma, JF | 1 |
Ekambaram, V | 1 |
Rao, MK | 1 |
Reddy, PK | 1 |
Ramachandran, A | 1 |
Seshadri, PS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients[NCT00669643] | Phase 4 | 859 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for dapsone and Leprosy, Borderline
Article | Year |
---|---|
Leprosy - an overview of clinical features, diagnosis, and treatment.
Topics: Adult; Aged; Child; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Progression; Drug Adminis | 2017 |
Leprosy. Recognition and treatment.
Topics: Adolescent; Adult; Age Factors; Biopsy; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Diagn | 2001 |
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced
Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Lepros | 1992 |
Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Topics: Dapsone; Drug Therapy, Combination; Ethiopia; Humans; Leprosy; Leprosy, Borderline; Leprosy, Leproma | 1992 |
4 trials available for dapsone and Leprosy, Borderline
Article | Year |
---|---|
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Interferon-gamma; Leprost | 1996 |
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial; | 1997 |
Does clofazimine have a prophylactic role against neuritis?
Topics: Adolescent; Adult; Case-Control Studies; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Hu | 1997 |
Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; | 1990 |
54 other studies available for dapsone and Leprosy, Borderline
Article | Year |
---|---|
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differe | 2021 |
Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report.
Topics: Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Th17 | 2018 |
A case of Hansen Disease presenting as tinea versicolor.
Topics: Clofazimine; Contraindications; Dapsone; Delayed Diagnosis; Diagnostic Errors; Humans; Hypesthesia; | 2013 |
[Borderline lepromatous leprosy].
Topics: Adult; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; | 2014 |
Optic nerve involvement in a borderline lepromatous leprosy patient on multidrug therapy.
Topics: Anti-Inflammatory Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; India; Leprostati | 2013 |
Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; M | 2015 |
Spared white islands in a drug rash: revisiting sparing phenomenon in Hansen's disease.
Topics: Adolescent; Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy, Borderline | 2017 |
Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Glucocorticoids; Humans; Lep | 2008 |
Two microbiological relapses in a patient with lepromatous leprosy.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Lepros | 2008 |
Leprosy: not always an easy diagnosis and often a management challenge.
Topics: Adult; Aged, 80 and over; Arm; Back; Clofazimine; Dapsone; Diagnosis, Differential; Drug Hypersensit | 2009 |
Facial tuberculoid leprosy: case report.
Topics: Adult; Cellulitis; Dapsone; Diagnosis, Differential; Facial Dermatoses; Female; Glucocorticoids; Hum | 2011 |
[Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Dapsone; Diagnostic Errors; Female; HIV Infections; | 2011 |
Facial reversal reaction: a dermatological emergency.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; B-Lymphocytes; CD3 Complex; Clofazim | 2012 |
A case of leprosy mistaken for cutaneous sarcoidosis.
Topics: Adult; Clofazimine; Dapsone; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Leprostat | 2012 |
A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
Topics: Agranulocytosis; Dapsone; Fatal Outcome; Humans; Leprosy, Borderline; Male; Middle Aged | 2003 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoi | 2005 |
Chronic inflammatory joint disease revealing borderline leprosy.
Topics: Adult; Arthritis; Chronic Disease; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Comb | 2006 |
First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
Topics: Acute Disease; Adult; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combin | 2006 |
Leprosy in a preschool child--a case report.
Topics: Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Fem | 2007 |
[Polyarthritis and papular eruption revealing leprosy].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Arthritis; Biopsy; Clofazimine; Dapsone; Drug | 2008 |
[Worsening of leprosy lesions in a Philippine-born patient].
Topics: Adult; Antigens, Bacterial; Dapsone; Facial Dermatoses; Fever; Humans; Leprostatic Agents; Leprosy, | 2008 |
Rhinosporidiosis in leprosy; a case report.
Topics: Antifungal Agents; Dapsone; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Nasa | 1995 |
Response of leprosy patients with single lesions to MDT.
Topics: Adolescent; Adult; Arm; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Hu | 1995 |
A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
Topics: Adolescent; Adult; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; Leprosy, | 1994 |
Dapsone syndrome.
Topics: Adolescent; Adult; Dapsone; Drug Eruptions; Female; Humans; Leprosy, Borderline; Leprosy, Tuberculoi | 1994 |
Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Topics: Adult; Aged; Confidence Intervals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; | 1994 |
Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; | 1993 |
Pedal edema following clofazimine therapy; a case report.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Foot Diseases; Humans; Leprosy, Borderline; | 1993 |
Serological monitoring of the response to chemotherapy in leprosy patients.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Child; Dapsone; Drug Resistance | 1993 |
Borderline-tuberculoid relapse in lepromatous leprosy.
Topics: Dapsone; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Midd | 1993 |
Use of steroids in dermatological emergencies.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antitubercular Agents; Child; Dapsone; Emergency Medical Serv | 1993 |
An unusual presentation of facial palsy in leprosy; a case report.
Topics: Aged; Dapsone; Facial Paralysis; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromato | 1995 |
Silent iritis in treated bacillary negative leprosy.
Topics: Aged; Dapsone; Drug Therapy, Combination; Female; Humans; Iritis; Leprostatic Agents; Leprosy, Borde | 1996 |
Dapsone-induced motor polyneuropathy in a patient with leprosy.
Topics: Adult; Anti-Inflammatory Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic | 1997 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocyte | 1998 |
Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Topics: Aged; Clofazimine; Dapsone; DNA, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; L | 2000 |
[What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy].
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lepros | 2002 |
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Carbohydrate Sequence; Clofazimine; Dapsone; Drug Therap | 1991 |
Fixed duration MDT in paucibacillary leprosy.
Topics: Adolescent; Adult; Aged; Child; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy | 1991 |
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; | 1991 |
Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Lep | 1991 |
Simultaneous occurrence of upgrading and downgrading type 1 (lepra) reaction.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Rifampin; | 1990 |
Effect of three-year multidrug therapy in multibacillary leprosy patients.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline | 1990 |
Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh).
Topics: Adolescent; Adult; Age Factors; Aged; Child; Dapsone; Disabled Persons; Female; Humans; India; Lepro | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Ison | 1989 |
Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; | 1989 |
[Secondary sulfone resistance--presentation of a case of leprosy-Oswaldo Cruz Foundation, Rio de Janeiro-Brazil].
Topics: Aged; Aged, 80 and over; Animals; Brazil; Dapsone; Drug Resistance, Microbial; Humans; Leprosy, Bord | 1989 |
Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Lepros | 1989 |
Bacillaemia in leprosy and effect of multidrug therapy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy | 1989 |
Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
Topics: Adolescent; Adult; Bilirubin; Body Weight; Child; Dapsone; Drug Administration Schedule; Erythrocyte | 1989 |
Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Topics: Adult; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; L | 1989 |
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; L | 1989 |
Occurrence of reversal reactions in BT patients during who paucibacillary leprosy MDT (1982).
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypersensitivity, | 1988 |
Relapse or reversal reaction: the case for a therapeutic trial of steroids.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Prednisolone; Recurren | 1988 |